The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis.
María Marques-VidasPaula López-SánchezFernando TorneroPedro GargantillaAlba MarotoAlberto Ortiz ArduanJose M PortolésPublished in: Clinical kidney journal (2022)
The prevalence of DKD among T2DM patients defined by lab data is significantly higher than that reported on hospital EMRs. This could imply underdiagnosis of DKD, especially in patients with the least severe disease who may benefit the most from optimized therapy.
Keyphrases
- data analysis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- type diabetes
- risk factors
- peritoneal dialysis
- metabolic syndrome
- stem cells
- patient reported outcomes
- bone marrow
- early onset
- big data
- adipose tissue
- mesenchymal stem cells
- adverse drug
- cell therapy
- glycemic control
- deep learning
- drug induced